JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 48(2014) N 4 p. 508-519; DOI 10.1134/S0026893314040153 Full Text

A.G. Soboleva*, A.V. Mezentsev, S.A. Brouskin

Genetically Modified Animals as Models of the Pathological Processes in Psoriasis

Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, 119991 Russia

*annasobo@mail.ru
Received - 2014-01-30; Accepted - 2014-03-06

Psoriasis is a chronic recurrent disorder that affects predominantly the skin and is autoimmune in nature. Experimental models help to study the development of psoriasis in controlled conditions and investigate particular aspects of the pathological process. Many mouse models were obtained to reproduce, to a certain extent, the psoriasis signs seen in humans. Genetically modified animals help to reveal the new genes whose mutations potentially underlie the disease and to search for new therapeutic targets. Moreover, the animal models are used to test new drugs and therapies. The review summarizes the published data on the laboratory animal models of the psoriatic process.

experimental model, genetically modified animals, psoriasis, biomarkers



JMB-FOOTER RAS-JOURNALS